These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 3031123
41. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole. Montani V, Shong M, Taniguchi SI, Suzuki K, Giuliani C, Napolitano G, Saito J, Saji M, Fiorentino B, Reimold AM, Singer DS, Kohn LD. Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427 [Abstract] [Full Text] [Related]
42. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Iwatani Y, Iitaka M, Row VV, Volpé R. Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474 [Abstract] [Full Text] [Related]
43. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG. Bodolay E, Szegedi G, Suranyi P, Juhasz F, Stenszky V, Balazs C, Farid NR. Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991 [Abstract] [Full Text] [Related]
44. Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo. Hoermann R, Schumm-Draeger PM, Rehbach K, Mann K. J Clin Invest; 1991 Dec; 88(6):1947-54. PubMed ID: 1752954 [Abstract] [Full Text] [Related]
51. CD4+ T cell-mediated cytotoxicity toward thyrocytes: the importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone. Kawakami A, Matsuoka N, Tsuboi M, Koji T, Urayama S, Sera N, Hida A, Usa T, Kimura H, Yokoyama N, Nakashima T, Ishikawa N, Ito K, Kawabe Y, Eguchi K. Lab Invest; 2000 Apr; 80(4):471-84. PubMed ID: 10780664 [Abstract] [Full Text] [Related]
52. Interferon-gamma inhibits thyroid-stimulating hormone-induced morphological changes and induces the expression of major histocompatibility complex class II antigen in thyroid follicles in suspension culture. Asakawa H, Hanafusa T, Katsura H, Miyagawa J, Otsuka A, Nakagawa C, Itoh N, Kono N, Tarui S. Endocrinology; 1991 Mar; 128(3):1409-13. PubMed ID: 1900229 [Abstract] [Full Text] [Related]
53. HLA-DR gene expression in a proliferating human thyroid cell clone (12S). Cone RD, Platzer M, Piccinini LA, Jaramillo M, Davies TF. Endocrinology; 1988 Oct; 123(4):2067-74. PubMed ID: 2843357 [Abstract] [Full Text] [Related]
58. FK506 inhibits phytohemagglutinin-, but not interferon-gamma-, induced HLA-DR antigen expression and accessory cell function on primary cultured human thyroid cells. Sato M, Hiromatsu Y, Tanaka K, Ishisaka N, Nonaka K. Acta Endocrinol (Copenh); 1993 Dec; 129(6):579-84. PubMed ID: 7509103 [Abstract] [Full Text] [Related]
59. Influence of cytokines on growth and differentiated function of FRTL5 cells. Zakarija M, McKenzie JM. Endocrinology; 1989 Sep; 125(3):1260-5. PubMed ID: 2474435 [Abstract] [Full Text] [Related]
60. Potentiation by thyroxine of interferon-gamma-induced HLA-DR expression is protein kinase A- and C-dependent. Lin HY, Thacore HR, Davis FB, Martino LJ, Davis PJ. J Interferon Cytokine Res; 1996 Jan; 16(1):17-24. PubMed ID: 8640446 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]